Keio University and LongeviQuest have signed a Memorandum of Understanding, effective August 6, 2024, concerning collaborative research activities on supercentenarians.
Purpose
This memorandum aims to have Keio University and LongeviQuest cooperate with each other, making effective use of both parties' resources to address the challenges of global aging and contribute to establishing a scientific knowledge base that supports “a society where everyone can enjoy health and longevity
.” This is the purpose of this memorandum.
Comment from LongeviQuest CEO Ben Meyers
“It is a great honor for LongeviQuest to collaborate with Keio University School of Medicine, which is globally renowned for its pioneering biomedical research. Supercentenarians teach us a great deal, and many of them wish to contribute to scientific progress. We hope this collaboration will help streamline that process.”
About Keio University School of Medicine
The Keio University School of Medicine Centenarian Research Center has been studying centenarians for more than 30 years. Making full use of its accumulated bioresources and leveraging advanced research techniques such as multi-omics and single-cell analysis, the center is engaged in translational longevity research aimed at creating new treatment and intervention strategies for age-related diseases.
About LongeviQuest
LongeviQuest, LLC (Florida, USA) is the world's foremost authority on age validation for the world's oldest people. Working with age validation experts around the world, it operates and publishes the leading database on the verified ages of the world's oldest supercentenarians (aged 110 and above).
